Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ITMCTR2026000418) titled 'Dendrobium Mixture on Mild Cognitive Impairment Associated with Type 2 Diabetes:Study protocol for a randomized controlled trial' on Feb. 25.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Third Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine
Condition:
Mild Cognitive Impairment Associated with Type 2 Diabetes
Intervention:
the dendrobium mixture group :All patients will receive metformin or other hypoglycemic drugs. The treatment group will receive Dendrobium officinale mixture 200 ml/day, 100 ml/time, orally after meals in the morning and e...